Antibiotics are one of the most effective ways to treat bacterial infections. However, they have been overprescribed and misprescribed for years, leading to the development of bacterial strains that are resistant to specific antibiotics.
The World Health Organization considers this one of the biggest threats to global health because antimicrobial resistant (AMR) infections kill more than 700,000 people worldwide every year.
Israeli researchers and entrepreneurs are approaching the problem from various different perspectives. Here are 10 promising advances.
- Customized antibiotics
The SNDA-AST diagnostic system, developed in the biomedical engineering lab of Prof. Shulamit Levenberg at the Technion-Israel Institute of Technology in Haifa, enables rapid and accurate antibiotic customization for each patient.
The point-of-care system, not yet commercialized, quickly analyzes bacteria isolated from urine samples and assesses their level of resistance to specific antibiotics. This enables the doctor to choose the most effective antibiotic immediately, rather than starting treatment with broad-spectrum antibiotics – which can cause AMR and kill “good” bacteria — while awaiting lab results from traditional cultures…
Full article on Israel21c